Arlington, VACIK 18464444 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
20 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Klaviyo Inc | 3.65M | $118.51M | 22.9% | +134.6K | Added |
| 2 | Nu Hldgs Ltd | 6.86M | $114.86M | 22.2% | −314.0K | Reduced |
| 3 | Beta Bionics Inc | 3.57M | $108.78M | 21.0% | 0 | Held |
| 4 | Inhibikase Therapeutics Inc |
| 13.02M |
| $26.69M |
| 5.1% |
| +2.07M |
| Added |
| 5 | Doordash Inc | 95.6K | $21.66M | 4.2% | +5.5K | Added |
| 6 | Coupang Inc | 870.4K | $20.53M | 4.0% | +75.4K | Added |
| 7 | Samsara Inc | 466.2K | $16.53M | 3.2% | −132.7K | Reduced |
| 8 | Datadog Inc | 85.8K | $11.67M | 2.3% | −32.9K | Reduced |
| 9 | Toast Inc | 301.6K | $10.71M | 2.1% | +145.0K | Added |
| 10 | Bioage Labs Inc | 786.4K | $10.40M | 2.0% | 0 | Held |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio